A review of human and analogue insulin trials.

A review of human and analogue insulin trials.

A recent meta-analysis evaluated trials of the rapid-acting analogues insulin lispro and insulin aspart, performed before the introduction of the basal analogues, insulin glargine and insulin detemir. This article reviews the effect of rapid-acting and basal insulin analogues separately and in combi...

Полное описание

Библиографические подробности
Главный автор:	Gough, S
Формат:	Journal article
Язык:	English
Опубликовано:	2007

Схожие документы

Engineering of insulin receptor isoform-selective insulin analogues.
по: Tine Glendorf, и др.
Опубликовано: (2011-01-01)

Molecular characterisation of long-acting insulin analogues in comparison with human insulin, IGF-1 and insulin X10.
по: Bo F Hansen, и др.
Опубликовано: (2012-01-01)

Insulin therapy and body weight: benefits of biphasic human insulin analogue NovoMix 30
по: Elena Viktorovna Surkova
Опубликовано: (2013-03-01)

Safety and Efficacy of Modern Insulin Analogues
по: Hye Jin Yoo, и др.
Опубликовано: (2013-06-01)

Análogos de insulina Insulin analogues
по: Manuel E. Licea Puig
Опубликовано: (2006-12-01)

Regular human insulins versus rapid-acting insulin analogues in children and adolescents with type 1 diabetes: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis
по: Johanne Juul Petersen, и др.
Опубликовано: (2025-01-01)

Insulin degludec is a new ultra-long-acting insulin analogue
по: Ivan Ivanovich Dedov, и др.
Опубликовано: (2014-07-01)

Insulin analogues and cancer: a note of caution
по: Joseph A.M.J.L. eJanssen, и др.
Опубликовано: (2014-05-01)

Insulin degludec/insulin aspart is the first co-formulation of basal and prandial insulin analogues
по: Ivan Ivanovich Dedov, и др.
Опубликовано: (2014-12-01)

Human versus Analogue Insulin for Youth with Type 1 Diabetes in Low-Resource Settings (HumAn-1): protocol for a randomised controlled trial
по: Éimhín Ansbro, и др.
Опубликовано: (2025-01-01)

Current european regulatory perspectives on insulin analogues
по: Enzmann Harald G, и др.
Опубликовано: (2011-07-01)

Cross-Reactivity of Insulin Immunoassays Important for Insulin Analogue Detection in Factitious Hypoglycaemia
по: Sachin K. Raj, и др.
Опубликовано: (2024-06-01)

Modern approach to the evaluation of the pharmacokinetics and pharmacodynamics of biosimilar recombinant human insulin and insulin analogues in I phase clinical study
по: Irina A. Proskurina, и др.
Опубликовано: (2016-07-01)

Health Technology Assessment on Insulin Analogues: the Rapid Review of Second Type Studies
по: A Oliyaeemanesh, и др.
Опубликовано: (2012-07-01)

Short-acting insulin analogues versus regular human insulin on postprandial glucose and hypoglycemia in type 1 diabetes mellitus: a systematic review and meta-analysis
по: Karla F. S. Melo, и др.
Опубликовано: (2019-01-01)

Determination of the Biological Activity of Insulin and Its Analogues in Animals
по: P. V. Shadrin, и др.
Опубликовано: (2023-07-01)

Comparative Study between the Glycemic Control of Human Insulin and Insulin analogue In Sample of Iraqi Type 1 Diabetic Children and Adolescents
по: Noor Wafaa Hashim, и др.
Опубликовано: (2018-12-01)

COMPARATIVE STUDY OF INTERACTION OF SOME DOMESTIC HUMAN INSULIN SUBSTANCES AND ITS ANALOGUES WITH INSULIN RECEPTOR BY METHOD OF SURFACE PLASMON RESONANCE
по: I. N. Urakova, и др.
Опубликовано: (2019-01-01)

Subcutaneous fast-acting insulin analogues, alone or in combination with long-acting insulin, versus intravenous regular insulin infusion in patients with diabetic ketoacidosis: protocol for an updated systematic review and meta-analysis of randomised trials
по: Beng Leong Lim, и др.
Опубликовано: (2023-02-01)

Systemically modeling the dynamics of plasma insulin insubcutaneous injection of insulin analogues for type 1 diabetes
по: Jiaxu Li, и др.
Опубликовано: (2008-11-01)

Insulin analogues: new therapies for type 2 diabetes mellitus.
по: Bethel, M, и др.
Опубликовано: (2002)

Modern Approaches to Determination of the Biological Activity of Insulin and Its Analogues
по: T. A. Batuashvili, и др.
Опубликовано: (2019-06-01)

Glycemic Effects of Once-a-Day Rapid-Acting Insulin Analogue Addition on a Basal Insulin Analogue in Korean Subjects with Poorly Controlled Type 2 Diabetes Mellitus
по: Eun Yeong Choe, и др.
Опубликовано: (2012-06-01)

Effect of human insulin and insulin analogue on some inflammatory markers and total antioxidant capacity in a sample of Iraqi type 1 diabetic children and adolescents
по: Noor Wafaa Hashim, и др.
Опубликовано: (2022-04-01)

Minimizing Mitogenic Potency of Insulin Analogues Through Modification of a Disulfide Bond
по: Shee Chee Ong, и др.
Опубликовано: (2022-06-01)

Prolonged control of insulin-dependent diabetes via intramuscular expression of plasmid-encoded single-strand insulin analogue
по: Lu Deng, и др.
Опубликовано: (2023-05-01)

Glucagon like peptide 1 analogue, Liraglutide, reduces adipose insulin resistance and hepatic de novo lipogenesis in Nonalcoholic Steatohepatitis: Sub-study results of a phase II randomised-control clinical trial
по: Armstrong, M, и др.
Опубликовано: (2013)

Biphasic insulin aspart in type 2 diabetes mellitus: an evidence-based medicine review.
по: Gough, S, и др.
Опубликовано: (2007)

Liraglutide, a human GLP-1 analogue, lowers HbA(1c) independent of weight loss
по: Schmidt, W, и др.
Опубликовано: (2009)

Insulin degludec: overview of a novel ultra long-acting basal insulin.
по: Gough, S, и др.
Опубликовано: (2013)

Insulin degludec: Overview of a novel ultra long-acting basal insulin
по: Gough, S, и др.
Опубликовано: (2013)

Individual stepwise intensification of insulin analogue therapy in type 2 diabetes mellitus
по: Alexander Sergeevich Ametov, и др.
Опубликовано: (2012-12-01)

Basal insulin analogues in the diabetes mellitus type 2 control — economic aspects
по: D. Yu. Belousov, и др.
Опубликовано: (2018-06-01)

Study of equivalence and comparable immunogenicity of biosimilar insulin aspart in comparison with the registered analogue
по: Т. L. Karonova, и др.
Опубликовано: (2022-06-01)

Insulin degludec: a new basal insulin analogue with an ultra-long duration of action. Safety and efficacy in Russian patients with diabetes
по: Marina Vladimirovna Shestakova, и др.
Опубликовано: (2015-12-01)

Use of human insulin analogues in young patients with type 1 diabetes mellitus: Results of the RESULT observational program on the use of insulin glargine (Lantus) in combination with insulin glulisine (Apidra) as a basal-bolus regimen
по: N V Efremova, и др.
Опубликовано: (2015-10-01)

Insulin resistance and alterations in the fibrinolytic system
по: Gough, S, и др.
Опубликовано: (1993)

Low-Volume Insulin Degludec 200 Units/mL Once Daily Improves Glycemic Control Similarly to Insulin Glargine With a Low Risk of Hypoglycemia in Insulin-Naive Patients With Type 2 Diabetes: A 26-week, randomized, controlled, multinational, treat-to-target trial: The BEGIN LOW VOLUME trial
по: Gough, S, и др.
Опубликовано: (2013)

Comparative analysis of glycemic control effectiveness and microvascular complications in patients with type 1 diabetes mellitus, treated with genetically engineered human insulin or human insulin analogues: A 10-year retrospective observational study
по: Marina V. Shestakova, и др.
Опубликовано: (2016-11-01)

SUBSTANTIATION ON SHORT TERM EFFICACY AND SAFETY OF INSULIN ANALOGUES IN NORTH INDIAN SUPERSPECIALITY HOSPITAL
по: Mohammad Ali Koladi, и др.
Опубликовано: (2014-07-01)